ESC Premium Access

State-of-the-art lipid treatment in coronary patients in 2017

Event: ESC CONGRESS 2017
Topic: Lipids (Epidemiology and Prevention)
Session type: Satellite Symposium
Sponsored by MSD
Date: 29 August 2017
Time: 12:45 - 13:45

Session

5 presentations in this session

A clinician's perspective on recent guidelines in clinical practice.

Speaker: Doctor M. Bonaca (Aurora, US)
Thumbnail

State-of-the-art lipid-lowering combination therapies.

Speaker: Professor F. Mach (Geneva, CH)
Thumbnail

Emerging science: recent evidence and science on the horizon.

Speaker: Professor E. Braunwald (Boston, US)
Thumbnail

Successes and challenges in clinical practice.

Speaker: Doctor C. Ballantyne (Houston, US)
Thumbnail

Audience Q&A - State-of-the-art-lipid treatment in coronary patients in 2017.

Speaker: Doctor M. Bonaca (Aurora, US)
Speaker: Professor E. Braunwald (Boston, US)
Speaker: Professor F. Mach (Geneva, CH)
Thumbnail

7 speakers from this session

Doctor Marc Bonaca

University of Colorado, Aurora (United States of America)
24 presentations
0 follower

Professor Francois Mach

Geneva University Hospitals, Geneva (Switzerland)
20 presentations
1 follower

Professor Eugene Braunwald

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
33 presentations
0 follower

Doctor Christie Ballantyne

Baylor College of Medicine, Houston (United States of America)
16 presentations
1 follower

Doctor Marc Bonaca

University of Colorado, Aurora (United States of America)
24 presentations
0 follower

Professor Eugene Braunwald

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
33 presentations
0 follower

Professor Francois Mach

Geneva University Hospitals, Geneva (Switzerland)
20 presentations
1 follower

This platform is supported by

logo Novo Nordisk